A recent study looked into the neural functions affected by ibuprofen and found some connections that may soon lead to a much greater understanding of the greatest pain mitigator of them all: the brain.
The US Food and Drug Administration (FDA) on Thursday approved Orkambi (lumacaftor/ivacaftor/Vertex) to treat cystic fibrosis patients age 12 and older with two copies of the F508del mutation in the CFTR gene.
Researchers from the University of California-Santa Barbara recently announced they have created an implantable “artificial pancreas” that could potentially eliminate the need for insulin injections and pumps for treating type 1 diabetes.
Michigan State University (MSU) researchers have created the first map to predict rotavirus (RV) prevalence on a global scale.
Discontinuation of multiple sclerosis medication saw nearly 2 in 5 patients experience some form of increased disease activity, according to research from NYU Langone Medical Center.
A novel virus from Peru and the Republic of Congo called enterovirus C105 is now suspected in last year's wave of mysterious cases of sudden childhood paralysis.
As more research is done the more it appears brown fat will play a key role in the future treatment of diabetes.